Large-scale testing (Phase 3)Study completedNCT01201356
What this trial is testing
Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis
Who this might be right for
Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 4,125